Literature DB >> 3325670

Operation for ascending aortic aneurysm and aortic regurgitation--pathological influence on survival.

H H Bentall1.   

Abstract

The author briefly reviews the early operations of treatment of aortic aneurysm and aortic regurgitation leading to his description, in 1968, of the first composite graft replacement of the ascending aorta and aortic valve, with anastomosis of the coronary arteries into the graft. The original operation is described with reference to modifications suggested by a number of authors throughout the last 20 years. Methods of achieving coronary artery continuity by Carrel patch and pull-through by saphenous vein interposition and by synthetic graft techniques are discussed. While any of these methods may be needed in individual cases the preference of the author remains for simplicity. The arguments for and against excision of the aneurysmal sac are considered in relation to the control of haemorrhage. The early and medium term results of operation are good but in comparing results world-wide a lack of uniform diagnostic criteria is apparent. The full clinical Marfan syndrome presents little difficulty but the status of "annuloaortic ectasia", Erdheim's medionecrosis, "cystic medial necrosis" and many other pathological descriptions are not defined: "forme fruste" of Marfan's disease has been used for any of the above. Interpretation of surgical results remains difficult and often impossible in the absence of clear definitions. Recent work on elastic tissue and on the chemistry of collagen together with the hope of identification of the genetic background now offers real hope of clearer understanding.

Entities:  

Mesh:

Year:  1987        PMID: 3325670     DOI: 10.1007/bf02470744

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  22 in total

1.  Cystic medial necrosis as a cause of localized aortic aneurysms amenable to surgical treatment.

Authors:  H T BAHNSON; A R NELSON
Journal:  Ann Surg       Date:  1956-10       Impact factor: 12.969

2.  A 38 base pair insertion in the pro alpha 2(I) collagen gene of a patient with Marfan syndrome.

Authors:  E Henke; M Leader; S Tajima; S Pinnell; R Kaufman
Journal:  J Cell Biochem       Date:  1985       Impact factor: 4.429

3.  Complete replacement of the ascending aorta and the aortic valve for the treatment of aortic aneurysm.

Authors:  M P Singh; H H Bentall
Journal:  J Thorac Cardiovasc Surg       Date:  1972-02       Impact factor: 5.209

4.  Aneurysm of the ascending aorta with aortic valvular insufficiency. Surgical management.

Authors:  R D Bloodwell; G L Hallman; D A Cooley
Journal:  Arch Surg       Date:  1966-04

5.  Length polymorphism in the pro alpha 2(I) collagen gene: an alternative explanation in a case of Marfan syndrome.

Authors:  R Dalgleish; G Williams; J R Hawkins
Journal:  Hum Genet       Date:  1986-05       Impact factor: 4.132

6.  Marfan syndrome: abnormal alpha 2 chain in type I collagen.

Authors:  P H Byers; R C Siegel; K E Peterson; D W Rowe; K A Holbrook; L T Smith; Y H Chang; J C Fu
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

7.  Marfan syndrome. Demonstration of abnormal elastin in aorta.

Authors:  P A Abraham; A J Perejda; W H Carnes; J Uitto
Journal:  J Clin Invest       Date:  1982-12       Impact factor: 14.808

8.  Collagen in human aorta. Changes in the type III/I ratio and concentration of the reducible crosslink, dehydrohydroxylysinonorleucine in ascending aorta from healthy subjects of different age and patients with annulo-aortic ectasia.

Authors:  T Halme; J Peltonen; T J Sims; T Vihersaari; R Penttinen
Journal:  Biochim Biophys Acta       Date:  1986-04-11

9.  Composite replacement of the aortic valve and ascending aorta.

Authors:  J E Mayer; W G Lindsay; Y Wang; C R Jorgensen; D M Nicoloff
Journal:  J Thorac Cardiovasc Surg       Date:  1978-12       Impact factor: 5.209

10.  Replacement of the ascending aorta and aortic valve with a composite graft. Results in 86 patients.

Authors:  N T Kouchoukos; R B Karp; E H Blackstone; J W Kirklin; A D Pacifico; G L Zorn
Journal:  Ann Surg       Date:  1980-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.